Merck results beat expectations on strong Keytruda sales, surprise Covid drug growth

Merck's revenue and earnings beat expectations, and it hiked its sales forecast while lowering its profit outlook.

from Health and Science https://ift.tt/LUEYdm8
https://ift.tt/kfIrZT4
https://ift.tt/qtLjmAk